Fundraising Fox
Arnatar Therapeutics
7 known investors
Find your way into Arnatar Therapeutics
Sign up to see every warm intro you have to Arnatar Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arnatar Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics. The platform serves pharmaceutical researchers and biotechnology companies developing treatments for genetic disorders and other disease areas.
Founders & leadership
Investors · 7
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
How we know: F-Prime Capital's portfolio page · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Arnatar Therapeutics do?
- Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics. The platform serves pharmaceutical researchers and biotechnology companies developing treatments for genetic disorders and other disease areas.
- Who founded Arnatar Therapeutics?
- Arnatar Therapeutics was founded by Dr. Xuehai Liang, Dr. Yanfeng Wang.
- Who are Arnatar Therapeutics's investors?
- Arnatar Therapeutics's investors include 3E Bioventures Capital, F-Prime Capital, Apricot Capital, Eight Roads Ventures, Gaorong Ventures, Legend Star, New Alliance Capital.